Provision of therapeutic drugs for gastrointestinal disorders such as diabetic gastric palsy. Component (A) and Component (B) are used as active ingredients, wherein both (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist are administered and used so that they act on the stomach after meals. A gastric motility enhancer in the late meal.
展开▼
